| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |